Summary: JACOBSON PHARMA (02633) reported Revenue of 1.39B（-12.12%）; Operating profit of 343.16M（-17.23%）; Net profit attributable to owners of 266.31M（-11.47%）.
ReportedYoY
Prior YearYoY
RevenueDown YoY
1.39B12.12%
1.58B18.51%
Operating profitDown YoY
343.16M17.23%
414.60M37.29%
Net profit attributable to ownersDown YoY
266.31M11.47%
300.83M24.30%
Revenue
ReportedUnit: HKD
Operating profit
ReportedUnit: HKD
Net profit attributable to owners
ReportedUnit: HKD
Gross marginYoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Profitability
(YoY)
Growth
(YoY)
Asset Quality
(YoY)
Cash Generation
(YoY)
RevenueYoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Revenue
(YoY)
Cost
(YoY)
Expenses
(YoY)
Interest
(YoY)
Income Tax
(YoY)
Profit
(YoY)
Cash and cash equivalentsYoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Assets
(YoY)
Liabilities
(YoY)
Equity
(YoY)
Net cash from operating activitiesYoY
Unit: HKD
FY 2014
FY 2015
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Operating Cash Flow
(YoY)
Investing Cash Flow
(YoY)
Financing Cash Flow
(YoY)
Net Change in Cash
(YoY)
Dividends
Dividend per share (last 12 months)
0.04 HKD
Dividend yield
+4.62%
Payments (last 12 months)
1
Sum of per-share cash dividends already ex-dividend, as of 2025-12-01; amounts in different currencies are not converted.
Dividend Details
Dividend Details
Ex-date
Payment Date
Record Date
HKD0.0475Final
HKD0.0425Interim每股派港币0.0425元
2025-12-01
2025-12-18
2025/12/03-2025/12/04
HKD0.055Final每股派港币0.055元
2025-08-11
2025-08-28
2025/08/13-2025/08/14
HKD0.06Special每股派港币0.06元
2025-08-11
2025-08-28
2025/08/13-2025/08/14
HKD0.035Interim每股派港币0.035元
2025-02-25
2025-04-02
2025/02/27-2025/02/28
HKD0.03Final每股派港币0.03元
2024-09-03
2024-10-04
2024/09/05-2024/09/06
HKD0.025Interim每股派港币0.025元
2023-12-18
2024-01-10
2023/12/20-2023/12/21
Special每持有2,000股股份获分派509股健倍苗苗股份
2023-08-15
2023-09-08
2023/08/17-2023/08/18
HKD0.0238Final每股派港币0.0238元
2023-08-15
2023-09-04
2023/08/17-2023/08/18
HKD0.028Interim每股派港币0.028元
2022-12-08
2022-12-29
2022/12/12-2022/12/13
HKD0.0268Final每股派港币0.0268元
2022-10-03
2022-10-18
2022/10/06-2022/10/07
HKD0.012Interim每股派港币0.012元
2021-12-09
2021-12-23
2021/12/13-2021/12/14
HKD0.015Final每股派港币0.015元
2021-10-05
2021-10-19
2021/10/07-2021/10/08
Special每持有8股股份可获分派1股健倍苗苗股份
2021-01-27
2021/01/29-2021/01/29
HKD0.008Interim每股派港币0.008元
2020-12-17
2021-01-06
2020/12/21-2020/12/22
HKD0.025Final每股派港币0.025元
2020-09-25
2020-10-13
2020/09/29-2020/09/30
HKD0.02Interim每股派港币0.02元
2019-12-06
2019-12-23
2019/12/10-2019/12/11
HKD0.03Final每股派港币0.03元
2019-08-30
2019-09-12
2019/09/03-2019/09/04
HKD0.015Interim每股派港币0.015元
2018-12-05
2018-12-21
2018/12/07-2018/12/10
HKD0.029Final每股派港币0.029元
2018-09-12
2018-09-27
2018/09/14-2018/09/17
HKD0.009Interim每股派港币0.009元
2017-11-27
2017-12-19
HKD0.014Final每股派港币0.014元
2017-09-12
2017-09-28
2017/09/14-2017/09/15
HKD0.008Interim每股派港币0.008元
2017-01-09
2017-01-20
2017/01/11-2017/01/13
Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.
About this page
This page shows JACOBSON PHARMA (02633) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.
